Accelerate Diagnostics Research and Development Expenses 2010-2024 | AXDX
Accelerate Diagnostics research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Accelerate Diagnostics Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $25 |
| 2022 | $27 |
| 2021 | $22 |
| 2020 | $21 |
| 2019 | $25 |
| 2018 | $28 |
| 2017 | $22 |
| 2016 | $30 |
| 2015 | $27 |
| 2014 | $20 |
| 2013 | $11 |
| 2012 | $ |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $1 |
| 2009 | $1 |
| Accelerate Diagnostics Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-09-30 | $4 |
| 2024-06-30 | $4 |
| 2024-03-31 | $5 |
| 2023-12-31 | $6 |
| 2023-09-30 | $7 |
| 2023-06-30 | $6 |
| 2023-03-31 | $7 |
| 2022-12-31 | $6 |
| 2022-09-30 | $7 |
| 2022-06-30 | $8 |
| 2022-03-31 | $6 |
| 2021-12-31 | $5 |
| 2021-09-30 | $5 |
| 2021-06-30 | $6 |
| 2021-03-31 | $7 |
| 2020-12-31 | $5 |
| 2020-09-30 | $5 |
| 2020-06-30 | $5 |
| 2020-03-31 | $6 |
| 2019-12-31 | $6 |
| 2019-09-30 | $6 |
| 2019-06-30 | $6 |
| 2019-03-31 | $7 |
| 2018-12-31 | $7 |
| 2018-09-30 | $8 |
| 2018-06-30 | $6 |
| 2018-03-31 | $7 |
| 2017-12-31 | $6 |
| 2017-09-30 | $6 |
| 2017-06-30 | $6 |
| 2017-03-31 | $4 |
| 2016-12-31 | $6 |
| 2016-09-30 | $8 |
| 2016-06-30 | $8 |
| 2016-03-31 | $8 |
| 2015-12-31 | $8 |
| 2015-09-30 | $6 |
| 2015-06-30 | $7 |
| 2015-03-31 | $6 |
| 2014-12-31 | $5 |
| 2014-09-30 | $6 |
| 2014-06-30 | $5 |
| 2014-03-31 | $4 |
| 2013-12-31 | $4 |
| 2013-09-30 | $3 |
| 2013-06-30 | $2 |
| 2013-03-31 | $2 |
| 2012-12-31 | |
| 2012-10-31 | $1 |
| 2012-09-30 | $0 |
| 2012-07-31 | |
| 2012-06-30 | $0 |
| 2012-04-30 | $0 |
| 2012-03-31 | $0 |
| 2012-01-31 | $0 |
| 2011-10-31 | $0 |
| 2011-07-31 | |
| 2011-04-30 | $0 |
| 2011-01-31 | $0 |
| 2010-10-31 | $0 |
| 2010-07-31 | |
| 2010-04-30 | $0 |
| 2010-01-31 | $0 |
| 2009-10-31 | $0 |
| 2009-07-31 | |
| 2009-04-30 | $0 |
| 2009-01-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.028B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $201.646B | 24.60 |
| Intuitive Surgical (ISRG) | United States | $191.920B | 100.34 |
| Edwards Lifesciences (EW) | United States | $44.778B | 28.43 |
| Alcon (ALC) | Switzerland | $42.567B | 28.48 |
| IQVIA Holdings (IQV) | United States | $36.345B | 20.02 |
| IDEXX Laboratories (IDXX) | United States | $34.155B | 40.22 |
| DexCom (DXCM) | United States | $31.470B | 47.39 |
| Waters (WAT) | United States | $22.372B | 33.08 |
| STERIS (STE) | Ireland | $20.602B | 23.72 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.912B | 0.00 |
| Hologic (HOLX) | United States | $16.503B | 17.82 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.421B | 13.78 |
| Sysmex ADR (SSMXY) | Japan | $11.599B | 36.37 |
| Globus Medical (GMED) | United States | $11.495B | 29.11 |
| Penumbra (PEN) | United States | $9.232B | 90.43 |
| Masimo (MASI) | United States | $9.157B | 44.31 |
| Glaukos (GKOS) | United States | $8.418B | 0.00 |
| Teleflex (TFX) | United States | $8.366B | 13.34 |
| Integer Holdings (ITGR) | United States | $4.558B | 25.83 |
| PROCEPT BioRobotics (PRCT) | United States | $4.359B | 0.00 |
| Veracyte (VCYT) | United States | $3.174B | 95.23 |
| Inari Medical (NARI) | United States | $3.163B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.555B | 14.75 |
| Nihon Kohden (NHNKY) | Japan | $2.490B | 18.91 |
| Tandem Diabetes Care (TNDM) | United States | $2.454B | 0.00 |
| TransMedics (TMDX) | United States | $2.101B | 66.60 |
| Elekta AB (EKTAY) | Sweden | $2.085B | 18.74 |
| Integra LifeSciences Holdings (IART) | United States | $1.752B | 9.15 |
| RxSight (RXST) | United States | $1.413B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.323B | 0.00 |
| Artivion (AORT) | United States | $1.230B | 81.50 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.037B | 0.00 |
| Paragon 28 (FNA) | United States | $0.867B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.743B | 12.62 |
| Mesa Laboratories (MLAB) | United States | $0.737B | 17.36 |
| AxoGen (AXGN) | United States | $0.736B | 0.00 |
| IRadimed (IRMD) | United States | $0.697B | 37.69 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.681B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.648B | 34.13 |
| SiBone (SIBN) | United States | $0.580B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.566B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.455B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.441B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.427B | 23.10 |
| Delcath Systems (DCTH) | United States | $0.383B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.366B | 0.00 |
| NeuroPace (NPCE) | United States | $0.339B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Inogen (INGN) | United States | $0.205B | 0.00 |
| Accuray (ARAY) | United States | $0.199B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.183B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.183B | 0.00 |
| Nevro (NVRO) | United States | $0.152B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.133B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.120B | 12.88 |
| Spectral Diagnostics (EDTXF) | Canada | $0.100B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.072B | 0.00 |
| 908 Devices (MASS) | United States | $0.071B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.064B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.060B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.045B | 0.00 |
| Neuronetics (STIM) | United States | $0.043B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.033B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| T2 Biosystems (TTOO) | United States | $0.009B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Avinger (AVGR) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |